Session

Basic aspects of GI neoplasia

INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT'S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING
INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT'S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING

GENETIC CLONAL DIVERSITY IN GASTRIC CANCER SURVEILLANCE BIOPSIES OF PROGRESSORS AND NON-PROGRESSORS
GENETIC CLONAL DIVERSITY IN GASTRIC CANCER SURVEILLANCE BIOPSIES OF PROGRESSORS AND NON-PROGRESSORS

DEFECT IN MIR-497 CONTRIBUTES THE TUMORIGENESIS AND PROGRESSION OF GASTRIC CANCER VIA REGULATING CDC42/ITGB1/FAK/PXN/AKT SIGNALING
DEFECT IN MIR-497 CONTRIBUTES THE TUMORIGENESIS AND PROGRESSION OF GASTRIC CANCER VIA REGULATING CDC42/ITGB1/FAK/PXN/AKT SIGNALING

AN OBJECTIVE RISK PREDICTION ASSAY ACCURATELY RISK STRATIFIES BARRETT'S ESOPHAGUS PATIENTS WITH LOW-GRADE DYSPLASIA
AN OBJECTIVE RISK PREDICTION ASSAY ACCURATELY RISK STRATIFIES BARRETT'S ESOPHAGUS PATIENTS WITH LOW-GRADE DYSPLASIA

ATM MUTATIONS AS A POTENTIAL BIOMARKER FOR IMMUNE CHECKPOINT THERAPY IN GASTRIC CANCER
ATM MUTATIONS AS A POTENTIAL BIOMARKER FOR IMMUNE CHECKPOINT THERAPY IN GASTRIC CANCER

PROTEOMICS SIGNATURE OF AUTOIMMUNE ATROPHIC GASTRITIS: TOWARDS A LINK WITH GASTRIC CANCER
PROTEOMICS SIGNATURE OF AUTOIMMUNE ATROPHIC GASTRITIS: TOWARDS A LINK WITH GASTRIC CANCER

DEFECT IN MIR-497 CONTRIBUTES THE TUMORIGENESIS AND PROGRESSION OF GASTRIC CANCER VIA REGULATING CDC42/ITGB1/FAK/PXN/AKT SIGNALING
DEFECT IN MIR-497 CONTRIBUTES THE TUMORIGENESIS AND PROGRESSION OF GASTRIC CANCER VIA REGULATING CDC42/ITGB1/FAK/PXN/AKT SIGNALING

Basic aspects of GI neoplasia

PROTEOMICS SIGNATURE OF AUTOIMMUNE ATROPHIC GASTRITIS: TOWARDS A LINK WITH GASTRIC CANCER
PROTEOMICS SIGNATURE OF AUTOIMMUNE ATROPHIC GASTRITIS: TOWARDS A LINK WITH GASTRIC CANCER

Basic aspects of GI neoplasia

AN OBJECTIVE RISK PREDICTION ASSAY ACCURATELY RISK STRATIFIES BARRETT’S ESOPHAGUS PATIENTS WITH LOW-GRADE DYSPLASIA
AN OBJECTIVE RISK PREDICTION ASSAY ACCURATELY RISK STRATIFIES BARRETT’S ESOPHAGUS PATIENTS WITH LOW-GRADE DYSPLASIA

Basic aspects of GI neoplasia

GENETIC CLONAL DIVERSITY IN GASTRIC CANCER SURVEILLANCE BIOPSIES OF PROGRESSORS AND NON-PROGRESSORS
GENETIC CLONAL DIVERSITY IN GASTRIC CANCER SURVEILLANCE BIOPSIES OF PROGRESSORS AND NON-PROGRESSORS

Basic aspects of GI neoplasia

ATM MUTATIONS AS A POTENTIAL BIOMARKER FOR IMMUNE CHECKPOINT THERAPY IN GASTRIC CANCER
ATM MUTATIONS AS A POTENTIAL BIOMARKER FOR IMMUNE CHECKPOINT THERAPY IN GASTRIC CANCER

Basic aspects of GI neoplasia

INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING
INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING

Basic aspects of GI neoplasia

PROTEOMICS SIGNATURE OF AUTOIMMUNE ATROPHIC GASTRITIS: TOWARDS A LINK WITH GASTRIC CANCER
PROTEOMICS SIGNATURE OF AUTOIMMUNE ATROPHIC GASTRITIS: TOWARDS A LINK WITH GASTRIC CANCER

Basic aspects of GI neoplasia  et al.

ATM MUTATIONS AS A POTENTIAL BIOMARKER FOR IMMUNE CHECKPOINT THERAPY IN GASTRIC CANCER
ATM MUTATIONS AS A POTENTIAL BIOMARKER FOR IMMUNE CHECKPOINT THERAPY IN GASTRIC CANCER

Basic aspects of GI neoplasia  et al.

AN OBJECTIVE RISK PREDICTION ASSAY ACCURATELY RISK STRATIFIES BARRETT’S ESOPHAGUS PATIENTS WITH LOW-GRADE DYSPLASIA
AN OBJECTIVE RISK PREDICTION ASSAY ACCURATELY RISK STRATIFIES BARRETT’S ESOPHAGUS PATIENTS WITH LOW-GRADE DYSPLASIA

Basic aspects of GI neoplasia  et al.

DEFECT IN MIR-497 CONTRIBUTES THE TUMORIGENESIS AND PROGRESSION OF GASTRIC CANCER VIA REGULATING CDC42/ITGB1/FAK/PXN/AKT SIGNALING
DEFECT IN MIR-497 CONTRIBUTES THE TUMORIGENESIS AND PROGRESSION OF GASTRIC CANCER VIA REGULATING CDC42/ITGB1/FAK/PXN/AKT SIGNALING

Basic aspects of GI neoplasia  et al.

GENETIC CLONAL DIVERSITY IN GASTRIC CANCER SURVEILLANCE BIOPSIES OF PROGRESSORS AND NON-PROGRESSORS
GENETIC CLONAL DIVERSITY IN GASTRIC CANCER SURVEILLANCE BIOPSIES OF PROGRESSORS AND NON-PROGRESSORS

Basic aspects of GI neoplasia  et al.

INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING
INHIBITORY EFFECT OF SLOW H2S-RELEASING DONOR (GYY4137) ON THE DEVELOPMENT OF BARRETT’S METAPLASIA-SPECIFIC MOLECULAR PROFILE AND INFLAMMATORY SIGNALING

Basic aspects of GI neoplasia  et al.

Item 1 - 18 / 18
1